Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma

Edward S. Kim, Merrill S. Kies, Frank V. Fossella, Bonnie S. Glisson, Sara Zaknoen, Paul Statkevich, Reginald F. Munden, Carmen Summey, Katherine M W Pisters, Vali Papadimitrakopoulou, Mourad Tighiouart, Andre Rogatko, Fadlo R. Khuri

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences